Abstract
The fibroblast-type cell found in hypertrophic scars and keloids demonstrates an elevated fibronectin (FN) production, compared to the same type of cell in normal dermis. We wished to determine if the effects of platelet derived growth factor (PDGF) on FN production in these cell types would be equivalent or different. Cell lines were established from the dermis (reticularis) of hypertrophic scars, keloids, uninvolved normal skin adjacent to the lesions, including an assumed normal skin adjacent to a keloid (AS), and normal skin from a different uninjured patient (DS). Each parent tissue from which the cell lines originated was diagnosed histologically. Each hypertrophic scar, keloid and normal adjacent skin, with one exception, showed typical histologic findings confirming the clinical diagnosis. DS was also normal. AS, although assumed to be normal, in fact, demonstrated portions of nodules from the adjacent keloid. All cell lines were grown under standard conditions with subconfluent cells metabolically labeled for radioimmunoassays measuring FN at passage 3 (8 to 9 weeks in culture) in the absence and presence of PDGF. Significant differences in production of FN/cell and FN/PR/cell between two hypertrophic scars and their matched normal skins and for one keloid and its matched normal skin were observed. However, no significant difference was observed between the other keloid and AS, nor between the other hypertrophic scar and DS. PDGF significantly stimulated FN production in 2 of 4 NS cell lines, and in the AS cell line. By FN/cell values, 2 of 5 cell lines from the lesions were inhibited and one was increased. In terms of FN/PR/cell, 1 of 5 cell lines from the lesions was stimulated and the others showed no differences. The mixed results may be attributable to the likelihood that the cell lines represent mixed populations. This study demonstrates the importance of: 1) histological characterization of all parent tissues from which cell lines are derived, and 2) matching cell lines from lesions with cell lines from uninvolved normal dermis, in the same individual.
Similar content being viewed by others
References
Babu M, Diegelmann R, Oliver N (1989) Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing. Mol. Cell. Biol. 9: 1642–1650.
Bernstein LR, Antoniades H, Zetter B (1983) Migration of cultured vascular cells in response to plasma and platelet derived factors. J. Cell. Sci. 56: 71–82.
Bolmer SD, Wolf G (1982) Stimulation of fibronectin production by retinoic acid in mouse skin tumors. Cancer. Res. 42: 4465–4472.
Clemmons DR, Van Wyk JJ (1981) Somatomedin-C and platelet-derived growth factor stimulate human fibroblast replication. J. Cell. Physiol. 106: 361–367.
Grinnell F (1982) Fibronectin and wound healing. Am. J. Dermatopathol. 4: 185–188.
Grinnell F (1984) Fibronectin and wound healing. J. Cell. Biochem. 26: 107–116.
Grinnell F, Billingham RE, Burgess L (1981) Distribution of fibronectin during wound healing in vivo. J. Invest. Dermatol. 76: 181–189.
Igisu K (1987) Increased production of fibronectin by fibroblasts from pre-cancerous scars. Br. J. Dermatol. 116: 79–86.
Kaplan DR, Chao FC, Stiles CD, Antoniades HN, Scher CD (1979) Platelet and granules contain a growth factor for fibroblasts. Blood 53: 1043–1052.
Kischer CW (1974a) Fibroblasts of the hypertrophic scar, mature scar and normal skin: a study by scanning and transmission electron microscopy. Tex. Rpts. Biol. Med. 32: 699–709.
Kischer CW (1974b) Collagen and dermal patterns in the hypertrophic scar. Anat. Rec. 179: 137–146.
Kischer CW, Brody GS (1981) Structure of the collagen nodule. Scanning Electron Microsc. 111: 371–376.
Kischer CW, Theis AC, Chvapil M (1982) Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Human Path. 13: 819–824.
Kischer CW, Hendrix MJC, (1983) Fibronectin (FN) in hypertrophic scars and kelloids Cell. Tissue Res. 231: 29–37.
Kischer CW, Wagner HN, Pindur J, Holubec H, Jones M, Ulreich JB, Scuderi P (1989) Increased fibronectin production by cell lines from hypertrophic scar and keloid. Conn. Tiss. Res. (In Press).
Kohler N, Lipton A (1974) Platelets as a source of fibroblast growth promotion activity. Exp. Cell. Res. 87: 297–301.
Mosher DF, Proctor RA, Grossman JE (1981) Fibronectin: Role in inflammation. Adv. Infl. Res. 2: 187–201.
Packham MA, Nishizawa EE, Mustard JF (1968) Response of platelets to tissue injury. Biochem. Pharmacol. 17 (suppl): 171–184.
Prins APA, Lipman JM, Sokoloff L (1982) Effect of purified growth factors on rabbit articular chondrocytes in monolayer culture. Arthritis Rheum. 25: 1217–1227.
Savage K, Siebert E, Swann D (1987) The effect of platelet-derived growth factor on cell division and glycosaminoglycan synthesis by human skin and scar fibroblasts. J. Invest. Dermatol. 89: 93–99.
Senior RM, Griffin GL, Huan JS, Wale DA, Deul TF (1983) Chemotactic activity of platelet alpha granule proteins for fibroblasts. J. Cell. Biol. 96: 382–385.
Seppa H, Grotendorst G, Seppa S, Schiffman E, Martin GR (1982) Platelet-derived growth factor is chemotactic for fibroblasts. J. Cell. Biol. 92: 584–588.
Shoshan S (1981) Wound healing. Int. Rev. Connect. Tiss. Res. 9: 1–26.
Smith FF, Tres LL, Kierszenbaum AL (1987) Ornithine decarboxylase activity during rat spermatogenesis in vivo and in vitro: selective effect of hormones and growth factors. J. Cell. Physiol. 133: 305–312.
Wharton W, Leof E, Olashaw N, O'Keefe EJ, Pledger WJ (1983) Mitogenic response to epidermal growth factor (EGF) modulated by platelet-derived growth factor in fibroblasts. Exp. Cell. Res. 147: 443–448.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kischer, C.W., Pindur, J. Effects of platelet derived growth factor (PDGF) on fibronectin (FN) production by human skin and scar fibroblasts. Cytotechnology 3, 231–238 (1990). https://doi.org/10.1007/BF00365486
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00365486